| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18799794 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 102 journal articles in the PubMed database | Email to a friend | | |
| Ginsberg HN, Ramakrishnan R
Kinetic studies of the metabolism of rapidly exchangeable apolipoproteins may leave investigators and readers with exchangeable results. [Comment, Editorial]
Arterioscler Thromb Vasc Biol 2008 Oct; 28(10):1685-6.
Full Citation | Publisher Full Text | Find Related Articles | | Chan DC, Watts GF, Ooi EM, et al.
Atorvastatin and Fenofibrate Have Comparable Effects on VLDL-Apolipoprotein C-III Kinetics in Men With the Metabolic Syndrome. [JOURNAL ARTICLE]
Arterioscler Thromb Vasc Biol 2008 Jun 19.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Watts GF, Barrett PH, Ji J, et al.
Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Diabetes 2003 Mar; 52(3):803-11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Christidis DS, Liberopoulos EN, Kakafika AI, et al.
The Effect of Apolipoprotein E Polymorphism on the Response to Lipid-Lowering Treatment With Atorvastatin or Fenofibrate. [JOURNAL ARTICLE]
J Cardiovasc Pharmacol Ther 2006 Sep; 11(3):211-221.
Abstract | Full Citation | Find Related Articles | | Nesto RW
Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome. [Journal Article, Review]
Am J Cardiovasc Drugs 2005; 5(6):379-87.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Sharma R, Mahajan M, Singh B, et al.
Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients. [Journal Article, Research Support, Non-U.S. Gov't]
J Indian Med Assoc 2006 Sep; 104(9):492-4, 496, 498.
Abstract | Full Citation | Find Related Articles | | Lemieux I, Salomon H, Després JP
Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Ann Med 2003; 35(6):442-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Le NA, Innis-Whitehouse W, Li X, et al.
Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Metabolism 2000 Feb; 49(2):167-77.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ooi EM, Watts GF, Chan DC, et al.
Dose-Dependent Effect of Rosuvastatin on Very-Low Density Lipoprotein- Apolipoprotein C-III Kinetics in the Metabolic Syndrome. [JOURNAL ARTICLE]
Diabetes Care 2008 May 28.
Abstract | Full Citation |   |
|
| |
Advertise on this site.
|
